These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29665754)

  • 1. The clinical manifestations and response to treatment in South Africans with lupus nephritis.
    Mody PG; Mody GM; Assounga A
    Lupus; 2018 Jun; 27(7):1207-1217. PubMed ID: 29665754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term renal survival of paediatric patients with lupus nephritis.
    Demir S; Gülhan B; Özen S; Çeleğen K; Batu ED; Taş N; Orhan D; Bilginer Y; Düzova A; Ozaltin F; Topaloğlu R
    Nephrol Dial Transplant; 2022 May; 37(6):1069-1077. PubMed ID: 33826705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis.
    Smith E; Al-Abadi E; Armon K; Bailey K; Ciurtin C; Davidson J; Gardner-Medwin J; Haslam K; Hawley D; Leahy A; Leone V; McErlane F; Mewar D; Modgil G; Moots R; Pilkington C; Ramanan A; Rangaraj S; Riley P; Sridhar A; Wilkinson N; Beresford MW; Hedrich CM
    Lupus; 2019 Apr; 28(5):613-620. PubMed ID: 30871425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome and predictors of renal survival in patients with lupus nephritis: Comparison between cyclophosphamide and mycophenolate mofetil.
    Joo YB; Kang YM; Kim HA; Suh CH; Kim TJ; Park YW; Lee J; Lee JH; Yoo DH; Bae SC; Lee HS; Bang SY
    Int J Rheum Dis; 2018 May; 21(5):1031-1039. PubMed ID: 29611341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term outcomes of severe lupus nephritis in a cohort of predominantly African-American children.
    Lau KK; Jones DP; Hastings MC; Gaber LW; Ault BH
    Pediatr Nephrol; 2006 May; 21(5):655-62. PubMed ID: 16570203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison Of Mycophenolate Mofetil And Cyclophosphamide As Lupus Nephritis Induction Therapy.
    Gul H; Mushtaq MS; Salim B; Samreen S; Nasim A; Khan M
    J Ayub Med Coll Abbottabad; 2020; 32(4):454-458. PubMed ID: 33225643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current therapies for lupus nephritis in an ethnically heterogeneous cohort.
    Rivera TL; Belmont HM; Malani S; Latorre M; Benton L; Weisstuch J; Barisoni L; Tseng CE; Izmirly PM; Buyon JP; Askanase AD
    J Rheumatol; 2009 Feb; 36(2):298-305. PubMed ID: 19040310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab use as induction therapy for lupus nephritis: a systematic review.
    Stolyar L; Lahita RG; Panush RS
    Lupus; 2020 Jul; 29(8):892-912. PubMed ID: 32486934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy.
    Nawata T; Kubo M; Fujii S; Shiragami K; Ikegami T; Kobayashi S; Hisano S; Yano M
    Intern Med; 2018 Jul; 57(14):2067-2070. PubMed ID: 29491296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D; Rodrigues M; da Silva JAP; Inês L
    Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis.
    Cooper JC; Rouster-Stevens K; Wright TB; Hsu JJ; Klein-Gitelman MS; Ardoin SP; Schanberg LE; Brunner HI; Eberhard BA; Wagner-Weiner L; Mehta J; Haines K; McCurdy DK; Phillips TA; Huang Z; von Scheven E;
    Pediatr Rheumatol Online J; 2018 Oct; 16(1):65. PubMed ID: 30348175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus glomerulonephritis in 788 Chinese children: a multi-centre clinical and histopathological analysis based on 549 renal biopsies.
    Jin SY; Huang DL; Dang XQ; Yi ZW
    Paediatr Int Child Health; 2017 Nov; 37(4):286-291. PubMed ID: 28463080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should mycophenolate mofetil replace cyclophosphamide as first-line therapy for severe lupus nephritis?
    Hogan J; Schwenk MH; Radhakrishnan J
    Kidney Int; 2012 Dec; 82(12):1256-60. PubMed ID: 22648298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycophenolate mofetil or cyclophosphamide in indian patients with lupus nephritis: Which is better? A single-center experience.
    Mendonca S; Gupta D; Ali S; Gupta P
    Saudi J Kidney Dis Transpl; 2017; 28(5):1069-1077. PubMed ID: 28937065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
    Groot N; de Graeff N; Marks SD; Brogan P; Avcin T; Bader-Meunier B; Dolezalova P; Feldman BM; Kone-Paut I; Lahdenne P; McCann L; Özen S; Pilkington CA; Ravelli A; Royen-Kerkhof AV; Uziel Y; Vastert BJ; Wulffraat NM; Beresford MW; Kamphuis S
    Ann Rheum Dis; 2017 Dec; 76(12):1965-1973. PubMed ID: 28877866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.